IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, providing promising enhancements throughout different health care and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, much more reliable alternative for therapeutic use